Chemours cuts earnings forecast on low demand, high input costs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Chemours (CC) PT Lowered to $46 at BMO Capital
September 22, 2022 12:32 PM EDTBMO Capital analyst John McNulty lowered the price target on Chemours (NYSE: CC) to $46.00 (from $55.00) while maintaining an Outperform rating.
The analyst commented, "CC continued the trend in the chemical arena and pre-announced Q3/2H results as Europe/Asia TiO2 demand in... More
